The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Cysteine cathepsin inhibitors as anti-Ebola agents

Ebola is a deadly disease that is currently wreaking havoc on parts of West Africa. There are currently no methods to cure infection and novel therapeutic drugs are in high demand. Dr. Kartik Chandran at Harvard Medical School (now at Albert Einstein) fou...
more information »

Multiple Myeloma Treatment with IRE1 Inhibitor

Researchers in Prof. Albert Koong’s laboratory identified a small molecule inhibitor of Ire1 (Inositol-requiring enzyme 1) that could be used to treat multiple myeloma. Ire1 is a ser/thr protein kinase with an endonuclease domain. Activation of the Ire1...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.